Madeleine Duvic1. Show Affiliations » 1. Department of Dermatology, University of Texas MD Anderson Cancer Center, Houston, TX.
Abstract
Entities: Disease
Mesh: See more » AlemtuzumabAminopterin/analogs & derivativesAminopterin/therapeutic useAntibodies, Monoclonal/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useAntineoplastic Combined Chemotherapy Protocols/therapeutic useBortezomib/therapeutic useClinical Trials as TopicDeoxycytidine/analogs & derivativesDeoxycytidine/therapeutic useDepsipeptides/therapeutic useDiphtheria Toxin/therapeutic useDisease ProgressionDoxorubicin/analogs & derivativesDoxorubicin/therapeutic useElectrons/therapeutic useHumansHydroxamic Acids/therapeutic useImmunotherapy/methodsIncidenceInterleukin-2/therapeutic useLenalidomideLymphoma, T-Cell/therapyMycosis Fungoides/therapyPentostatin/therapeutic usePhotopheresis/methodsPolyethylene Glycols/therapeutic useRandomized Controlled Trials as TopicRecombinant Fusion Proteins/therapeutic useRetinoids/therapeutic useSezary Syndrome/therapyStem Cell Transplantation/methodsThalidomide/analogs & derivativesThalidomide/therapeutic useUnited StatesVorinostat
Substances: See more » 10-propargyl-10-deazaaminopterinAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedDepsipeptidesDiphtheria ToxinHydroxamic AcidsInterleukin-2Recombinant Fusion ProteinsRetinoidsliposomal doxorubicinDeoxycytidinedenileukin diftitoxPentostatinAlemtuzumabPolyethylene GlycolsThalidomideVorinostatBortezomibDoxorubicingemcitabineromidepsinLenalidomideAminopterinmogamulizumab
Year: 2015 PMID: 26637769 DOI: 10.1182/asheducation-2015.1.529
Source DB: PubMed Journal: Hematology Am Soc Hematol Educ Program ISSN: 1520-4383